Utah Medical Products
UTMD
112 hedge funds and large institutions have $142M invested in Utah Medical Products in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 17 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 35
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
2% more funds holding
Funds holding: 110 → 112 (+2)
1.21% less ownership
Funds ownership: 69.21% → 68% (-1.2%)
12% less capital invested
Capital invested by funds: $161M → $142M (-$19.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
+$2.33M |
| 2 |
HCM
Huber Capital Management
El Segundo,
California
|
+$1.85M |
| 3 |
RA
Royce & Associates
New York
|
+$1.67M |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.59M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$724K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.4M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$894K |
| 3 |
BlackRock
New York
|
-$742K |
| 4 |
Man Group
London,
United Kingdom
|
-$679K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$594K |
UTMD Hedge Fund Activity: Q4 2024 in Review
112 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2024, worth a combined $142M — down 12% from $161M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new UTMD positions and 17 closed out — a net gain of 2 holders — while 41 added to existing stakes and 35 trimmed.
The largest buyer was Minerva Advisors, adding an estimated $2.33M. The largest seller was Fidelity Investments, cutting an estimated $11.4M.
- 112 institutional investors held Utah Medical Products (UTMD) as of Q4 2024, up from 110 in Q3 2024.
- Funds reported $142M of Utah Medical Products stock for Q4 2024, down 12% quarter-over-quarter.
- 19 funds opened new Utah Medical Products positions in Q4 2024 and 17 closed out, a net change of +2 holders.
- The largest Utah Medical Products buyer in Q4 2024 was Minerva Advisors, an estimated $2.33M added.
- The largest Utah Medical Products seller in Q4 2024 was Fidelity Investments, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2024.